immunotherapy

Isticmaalka Immunotherapy si loogu daweeyo Kaansarka Marxaladda Dambe

  Horudhac Immunotherapy waxa ay noqotay hab horudhac u ah daawaynta kansarka, gaar ahaan daawaynta kansarka heer-sare ee muujiyay waxtarka ugu yar ee daawooyinka caadiga ah. Appr-kan hal-abuurka leh

Tumor-Infiltrating Lymphocyte (TIL) Therapy ee Shiinaha

Feb 2024: Tumor-infiltrating lymphocyte (TIL) therapy treatment is a potential method that utilizes the body's immune system to fight solid tumors. This therapeutic area in China is advancing rapidly because of the nation's incr..

Daawaynta Kansarka Bilaashka Ah Ee Shiinaha Adoon Jebin Banka: Hagaha Kuwa Inta Badan U Baahan

Daawaynta kansarka bilaashka ah ee Shiinaha ayaa rajo iyo bogsiin siinaysa dadka u baahan. Markaa, haddii aadan awoodin inaad doorato daawaynta kansarka sababtoo ah kharashkeeda badan, hagahan si gaar ah ayaa adiga loogu talagalay. Soo ogow sida loo yaqaan organiz

Doorka Immunotherapy ee Daaweynta Lymphoma

Haddii aad tan akhrinayso, adiga ama laga yaabaa in mid ka mid ah kuwa aad jeceshahay uu ku jiro safar aan qofna waligiis qorsheynin inuu qaado - dariiqa loo maro kansarka. Waxaan fahamsanahay in waddadan ay ka buuxaan hubanti la'aan, cabsi, iyo daqiiqado marka la dareemo.

TIL immunotherapy, TILs therapy, Burada Soo Galitaanka Lymphocytes

Tumor Infiltrating lymphocytes (TIL) Immunotherapy gudaha Hindiya

Abriil 2023: Isticmaalka habka difaaca jidhka si loola dagaallamo unugyada kansarka waa yoolka habka daawaynta kansarka ee rajo-gelinta ah ee loo yaqaan buro infiltrating lymphocytes (TIL) immunotherapy. Nidaamku wuxuu ka kooban yahay qaadashada unugyada difaaca ee loo yaqaan TI.

Bulshada Mareykanka ee Cudurka Cudurka Hematology, Carteyva, Shiinaha, Daawooyinka JW, relmacabtagene autoleucel

Dawaynta JW waxay soo bandhigaysaa Xogta Caafimaad ee Ugu Danbaysay ee Carteyva® ee Lymphoma Follicular Lymphoma iyo Mantle Cell Lymphoma kulanka Sannadlaha ah ee 64aad ee ASH

SHANGHAI, CHINA, Diseembar 12, 2022 Shirkad bayotechnoolajiyada madax-bannaan oo hal abuur leh oo la yiraahdo JW Therapeutics (HKEX: 2126) waxay diiradda saartaa horumarinta, soo saarista, iyo iibinta alaabada tallaalka unugyada. Ururka 64-aad ee Maraykanka.

Daaweynta unugyada, Shiinaha, Daawooyinka JW, Shanghai

JW Therapeutics waxay ku dhawaaqday in Dawooyinka Immunotherapy-ga unuggu ay si guul leh uga faa'iideysteen 300 bukaan

SHANGHAI, CHINA, Noofambar 9, 2022 - JW Therapeutics (HKEX: 2126), shirkad madax-bannaan oo tignoolajiyada cusub leh oo diiradda saaraysa horumarinta, soo saarista, iyo ka-ganacsiga alaabada tallaalka unugyada, ayaa ku dhawaaqday in laga bilaabo N..

2 iyo todobaatan bio, Shiinaha, immunotherapy, Daawooyinka JW, Partnership

JW Therapeutics iyo 2 bio ayaa ku dhawaaqay iskaashiga istiraatijiyadeed si loo dardargeliyo cilmi baarista iyo horumarinta daawoyinka difaaca jirka ee T-cell

SHANGHAI, CHINA iyo CAMBRIDGE, MASSACHUSETTS, US, Oktoobar 27, 2022 - JW Therapeutics (HKEX: 2126), shirkad madax-bannaan oo hal-abuur leh bayotechnoolajiyada diiradda saaraya horumarinta, soo saarista, iyo ganacsiyaynta immunotherap unug.

KEYTRUDA, Merck, Pembrolizumab, Cudurka Roche Tissue Diagnostics, Nidaamyada Caafimaadka ee Ventana

Pembrolizumab waxaa loo oggolaaday kansarka endometrial sare

Abriil 2022: Pembrolizumab (Keytruda, Merck) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka sidii hal wakiil oo loogu talagalay bukaannada qaba kansarka endometrial sare oo ah xasillooni-darro-sare (MSI-H) ama dayactir la'aanta de..

PD-1 difaaca jirka ee difaaca jirka ee unugyada B cell lymphoma

Dib-u-eegis ay qoreen Young, MD, Xarunta Kansarka ee Anderson, USA waxay sharraxday dalabka PD-1 inhibitor immunotherapy ee B-cell lymphoma. (Dhiig. Nooca khadka tooska ah Noofeembar 8, 2017. doi: 10.1182 / blood-2017-07-740993.) PD-1 difaaca ..